Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
- 1 June 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 17 (6_pt_2) , 1038-1044
- https://doi.org/10.1161/01.hyp.17.6.1038
Abstract
The role of angiotensin II and kinins on the renal cortical and papillary hemodynamic and on the sodium and water excretory responses to converting enzyme inhibition with captopril was examined in euvolemic Munich-Wistar rats. Cortical and papillary blood flows were measured using a laser Doppler flowmeter. Cortical blood flow increased 28% after blockade of angiotensin II receptors with DuP 753 (2 mg/kg i.v., n = 6). Captopril (2 mg/kg i.v., n = 6) had no effect on cortical blood flow in rats pretreated with the angiotensin II antagonist. DuP 753 had no effect on papillary blood flow, nor did it prevent the rise in papillary blood flow produced by captopril (2 mg/kg, n = 6). Infusion of a kinin receptor antagonist, D-Arg, [Hyp3,Thi5,8,D-Phe7]-bradykinin (2.5 micrograms/min i.v.), reduced basal papillary blood flow by 15% and blocked the rise in papillary blood flow produced by captopril. Renal blood flow rose by 11% after DuP 753 (2 mg/kg, n = 6), and subsequent administration of captopril and the kinin antagonist had no effect on renal blood flow. Urine flow and sodium excretion increased after DuP 753, but captopril produced additional increases in urine flow and sodium excretion of 68% and 46% respectively. Fractional sodium excretion rose from 0.85 +/- 0.15% to 1.56 +/- 0.14% after captopril. Infusion of the kinin antagonist returned sodium and water excretion to control levels, but fractional sodium excretion was not significantly altered. Glomerular filtration rate was not altered by DuP 753 or captopril; however, it fell from 1.6 +/- 0.1 to 1.2 +/- 0.1 ml/min/g kidney wt during infusion of the kinin antagonist.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 21 references indexed in Scilit:
- Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension.Hypertension, 1988
- Effect of captopril and hydralazine on arterial pressure-urinary output relationships in spontaneously hypertensive rats.Hypertension, 1987
- The role of renal hemodynamics in the antihypertensive effect of captoprilAmerican Heart Journal, 1986
- Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitorsKidney International, 1984
- ROLE OF THE KALLIKREIN-KININ SYSTEM IN THE RENAL EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN ANAESTHETIZED DOGSClinical and Experimental Pharmacology and Physiology, 1981
- Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.Hypertension, 1981
- Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril.Hypertension, 1981
- Vasodepressor Property of the Converting Enzyme Inhibitor Captopril (SQ 14 225): The Role of Factors other than Renin-Angiotensin Blockade in the RatClinical Science, 1980
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Effect of inhibition of peptidase activity on distribution of intrarenal blood flowAmerican Journal of Physiology-Legacy Content, 1975